IL9 and melanoma: Interestingly, the Th2 cytokine IL-5 was significantly increased in the plasma of NAM-treated melanoma-bearing mice, while IL-12 (p40), a typical Th1 cytokine, was decreased, indicating a shift toward a Th2 profile in NAM-treated melanoma-bearing mice.